Head-to-head · WeighScore
Kin Meds vs NuvaHealth
By GLP-1 ScorecardUpdated
Score comparison
NuvaHealth has the higher recorded score — 74.2/100 to 69.1/100.
NuvaHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuvaHealth (nuvahealth.org) is a LegitScript-certified compounded GLP-1 telehealth platform offering compounded semaglutide starting at $159 first-month and compounded tirzepatide starting at $259 first-month.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Kin Meds | NuvaHealth |
|---|---|---|
| WeighScore | 69.1/100 | 74.2/100 |
| Grade | C | C |
| Site position | #148 | #73 |
| Semaglutide | $149/mo (brand Wegovy) | $139/mo (first-month rate, compounded) |
| Tirzepatide | $149/mo (brand Zepbound) | $229/mo (first-month rate, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #148 · C
FDAWarning letter issued to Kin Meds in February 2026. See the FDA warning-letter database.
Strengths
- Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
- Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
- LegitScript verified
- Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
- Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health
What to consider
- Legal entity name and state of incorporation not publicly disclosed
- The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
- Per-state availability not listed
- $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
- FDA issued Kin Meds a warning letter in February 2026; the letter is public in FDA's warning-letter database
Site position #73 · C
Strengths
- LegitScript Certified seal displayed on the marketing site (the standard third-party telehealth/pharmacy accreditation)
- Free and fast delivery + 24/7 patient support disclosed on the home page
- Newark, DE address suggests a US-incorporated entity (vs offshore)
- $139 first-month price for compounded semaglutide injection is among the cheapest in the US compounded telehealth market
- $229 first-month price for compounded tirzepatide injection sits in the lower-median range
What to consider
- Standard ongoing monthly price NOT publicly disclosed (gated behind checkout) — patients should ask for the maintenance-dose price before committing
- Specific legal entity name + state of incorporation NOT publicly disclosed on the home page — a material transparency gap for a health purchase
- Pharmacy partners NOT publicly named — a material transparency gap for a health purchase
- Per-state availability NOT enumerated; verify your state ships before purchase
- Lab work + coaching support NOT publicly disclosed
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.